RecruitingNCT05177809
RFC1 Natural History Study
Studying Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Prof. Dr. Matthis Synofzik
- Principal Investigator
- Matthis Synofzik, Prof. Dr.University Hospital Tübingen
- Intervention
- Clinical rating scale to measure ataxia disease severity and progression(other)
- Enrollment
- 150 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2026
Study locations (10)
- Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Victoria, Australia
- Department of Neurology, Ataxia Unit, Universidade Federal de São Paulo, São Paulo, State of São Paulo, Brazil
- Service de Neurologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, Strasbourg, France
- Center for Neurology & Hertie-Institute for Clinical Brain Research, Dept. for Neurodegenerative Diseases, Tübingen, Baden-Wurttemberg, Germany
- German Center for Neurodegenerative Diseases (DZNE), Bonn, North Rhine-Westphalia, Germany
- Department of Neurology University Hospital Schleswig Holstein, Lübeck, Schleswig-Holstein, Germany
- Università degli Studi di Napoli 'Federico II', c/o AOU Federico II, Naples, Napoli, Italy
- IRCCS Fondazione Stella Maris, Pisa, Italy
- Centre of Brain Research Neurogenetics Research Clinic, University of Auckland, Auckland, New Zealand
- Koç University Hospital, KUTTAM-NDAL, Istanbul, Turkey (Türkiye)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05177809 on ClinicalTrials.govOther trials for Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE2NCT0754382224VA022; VATCH Alpelisib for TIE2/PIK3CA Pathway VAsChildren's Hospital of Philadelphia
- ACTIVE NOT RECRUITINGPHASE2NCT0754964624VA021; VATCH Trametinib for Ras/MAPK Pathway VAsChildren's Hospital of Philadelphia
- RECRUITINGNANCT06817707Evaluation of Urinary Dysfunction in CANVAS PatientsCentre Hospitalier Universitaire de Nice
- RECRUITINGNANCT07156214Pathogenic Insights and Search for Biomarkers in RFC1-ataxia/CANVASCatholic University of the Sacred Heart
See all trials for Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome →